Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gaush Meditech is a leading Chinese provider of ophthalmic medical devices and consumables. The company develops, manufactures, and distributes a wide range of products for diagnosis, treatment, and surgery across seven major sub-specialties in ophthalmology. It is publicly listed on the Hong Kong Stock Exchange since December 2022.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gaush Meditech.